Cargando…
Correlation between PD-L1 expression (clones 28-8 and SP263) and histopathology in lung adenocarcinoma
Lung cancer is the leading cause of cancer-related death worldwide. Recent advances in the management of non-small cell carcinoma are focused on the discovery of targeted therapies and novel immunotherapy strategies for patients with advanced disease. Treatment with anti PD-(L)1 immune checkpoint in...
Autores principales: | García, Alejandro, Recondo, Gonzalo, Greco, Martín, de la Vega, Máximo, Perazzo, Florencia, Avagnina, Alejandra, Denninghoff, Valeria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267734/ https://www.ncbi.nlm.nih.gov/pubmed/32514486 http://dx.doi.org/10.1016/j.heliyon.2020.e04117 |
Ejemplares similares
-
Non-small-cell lung cancer: how to manage MET exon 14 skipping mutant disease
por: Blaquier, Juan Bautista, et al.
Publicado: (2022) -
Novel approaches to target HER2-positive breast cancer: trastuzumab emtansine
por: Recondo, Gonzalo, et al.
Publicado: (2016) -
Immunohistochemical characterization of neoplastic cells of breast origin
por: Noriega, MariadelasMercedes, et al.
Publicado: (2012) -
Resistance to KRAS(G12C) Inhibitors in Non-Small Cell Lung Cancer
por: Blaquier, Juan Bautista, et al.
Publicado: (2021) -
Quantitative and qualitative characterization of Two PD-L1 clones: SP263 and E1L3N
por: Smith, Jacquelyn, et al.
Publicado: (2016)